Skip to content
★ Sign in to follow
SI

SourceBio International PLC Stock: price and insider trades · United Kingdom

ISIN GB00BKSB1674GB·

No insider purchase over the last 90 days. The latest, by Harwood Capital LLP as investment manager, was filed 25 Nov 2020.

SourceBio International PLC: what insiders have been doing

Every trade that managers of SourceBio International PLC disclose to RNS (LSE) is tracked on this page. The past year has been quiet: not a single insider filing for SourceBio International PLC. The previous disclosure was published on 11 May 2022.

Looking back to 2020, when coverage begins, insiders filed 2 purchases and 6 sales.

Other companies in the same market with recent insider buying flagged by our signals: CMC Markets plc. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Insider Decl.
28
Thresholds
n/a
Buy Volume
€98,235
2 ops. · all time
Sell Volume
€2M
6 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Last declaration on 11 May 2022
Declarations28 total

25 of 28 declarations

About SourceBio International PLC

SourceBio International PLC is a company specializing in biotechnology and diagnostic services. It provides solutions for research and development in the healthcare sector.